Muhurat Trading 2026: Sensex, Nifty open higher in special session; Tata Steel, Sun Pharma shares among top gainers
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓Sensex and Nifty opened higher during the special Muhurat Trading 2026 session on Sunday, November 8.
- ✓The gains marked an eight-session winning streak for domestic indices.
- ✓Tata Steel and Sun Pharma shares emerged as top gainers.
Story at a Glance
- Category
- Indian Markets
- Reported By
- Business Today
- Reading Speed
- 2 Minute(s)
- Market Focus
- India Economy
Indian equity benchmarks, NSE Nifty and BSE Sensex, opened higher during the special Muhurat Trading 2026 session on Sunday, November 8, held on the occasion of Diwali Laxmi Pujan. The gains extended the domestic indices' winning streak to eight consecutive sessions. At the last check, the 30-share Sensex pack was up 321.29 points or 0.40 per cent to trade at 81,349.31, while the Nifty index climbed 73.15 points or 0.29 per cent to 25,103.50 level.
Tata Steel Ltd, Sun Pharmaceutical Industries Ltd, BSE Ltd, Tata Motors Passenger Vehicles Ltd (TMPV) and UltraTech Cement were among the top gainers on Nifty, rising up to 4.68 per cent.
The 70-minute trading session will remain open until 3:30 pm. Muhurat trading is a special trading session held every year on Diwali. Coinciding with Lakshmi Puja, investors and traders consider the session auspicious, and it marks the beginning of Vikram Samvat, or the Hindu financial year.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
Business Today
Read the full, original unfiltered story directly on the publisher's portal.
This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.